Results 121 to 130 of about 23,057 (164)

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase. [PDF]

open access: yesTheranostics, 2018
Dong JK   +13 more
europepmc   +1 more source

Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. [PDF]

open access: yesACS Chem Biol, 2015
Fan J   +7 more
europepmc   +1 more source

Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015–2020

open access: yesExpert Opinion on Therapeutic Patents, 2021
Introduction:The phosphoglycerate dehydrogenase (PHGDH), a metabolic enzyme involved in the serine synthetic pathway (SSP), appears to play a central role in supporting cancer growth and proliferation. PHGDH is a dehydrogenase whose expression in cancers was first demonstrated in 2010.
Raphaël Frederick
exaly   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Prognostic significance of phosphoglycerate dehydrogenase in breast cancer

Breast Cancer Research and Treatment, 2021
Breast cancer is the most common type of cancer affecting women worldwide. Phosphoglycerate dehydrogenase (PHGDH) is an oxidoreductase in the serine biosynthesis pathway. Although it has been reported to affect growth of various tumors, its role in breast cancer is largely unknown.
Muthukrishnan Chandrika   +8 more
openaire   +2 more sources

Multiconformational States in Phosphoglycerate Dehydrogenase,

Biochemistry, 2004
Phosphoglycerate dehydrogenase (PGDH) catalyzes the first step in the serine biosynthetic pathway. In lower plants and bacteria, the PGDH reaction is regulated by the end-product of the pathway, serine. The regulation occurs through a V(max) mechanism with serine binding and inhibition occurring in a cooperative manner.
Jessica K, Bell   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy